ACUMENTIS GROUP LIMITED (ACU)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for ACU during the last 90 days, indicating Moderate trading activity

Latest ACU Signals
01/05/2026	BUY
16/04/2026	BUY
01/04/2026	BUY
ACU Share Price
Current Price	$0.078
52 Week High	$0.085
52 Week Low:	$0.066
Trading at (% of 52 Week High)	91.76%

Business Overview

Acumentis Group Limited (ASX: ACU) provides property-related services focused on risk management and valuation. The company offers valuation advice, asset management, and related consulting services to financial institutions, government bodies, and corporations across Australia.

ASX Sector Overview

Sector:   Real Estate Management & Development

The Real Estate Management & Development sector on the ASX involves companies that develop, manage, and operate real estate properties. These companies often handle residential, commercial, and industrial properties, including the planning, construction, leasing, and maintenance of buildings. The sector plays a key role in shaping urban growth and infrastructure development. It is influenced by factors such as property market conditions, interest rates, and government policies related to land use and zoning.

Latest AI Recommendation

The BUY signal for ACUMENTIS GROUP LIMITED at the current price of 0.0850 is supported by positive momentum indicators and potential undervaluation. However, the relatively low liquidity and limited market capitalization introduce moderate risk, warranting a cautious approach.

Latest  ACUMENTIS GROUP LIMITED(ACU)   News

18 Jun 2025, 02:57 AM

Citi initiates coverage on biotech amid improving sentiment in sector

Investing.com -- Citi initiated coverage on small- and mid-cap biotechnology companies on early signs of improving sentiment in a sector weighed down this year by policy uncertainty and weak investor interest. The brokerage launched with Buy ratings on Acumen, Amylyx, Arcellx, NewAmsterdam Pharma,